(Q40750412)

English

Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex

scientific article published on February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

antimycobacterial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mycobacterium avium avium

1 reference

based on heuristic

inferred from title

Haruaki Tomioka

1

object named as

Haruaki Tomioka

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Chiaki Sano

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Katsumasa Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Toshiaki Shimizu

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

139-145

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

The Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin against Mycobacterium avium complex infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials in Mycobacterium avium therapy: lessons to take home.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of disseminated Mycobacterium avium complex disease: a clinician's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study G

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacteria and the new quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical use of fluoroquinolones for the treatment of mycobacterial diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospects for development of new antimycobacterial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility testing of Mycobacterium avium complex isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of the fractional maximal effect method: comparative interaction studies of ciprofloxacin and protein synthesis inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Promoter-specific inhibition of transcription by antibiotics which act on DNA gyrase

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900473-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(01)00473-3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40750412&oldid=2191139003"